Comp34 displays potent preclinical antitumor efficacy in triple-negative breast cancer via inhibition of NUDT3-AS4, a novel oncogenic long noncoding RNA.
Hao Q, Wang P, Dutta P, Chung S, Li Q, Wang K, Li J, Cao W, Deng W, Geng Q, Schrode K, Shaheen M, Wu K, Zhu D, Chen QH, Chen G, Elshimali Y, Vadgama J, Wu Y.
Hao Q, et al. Among authors: cao w.
Cell Death Dis. 2020 Dec 11;11(12):1052. doi: 10.1038/s41419-020-03235-w.
Cell Death Dis. 2020.
PMID: 33311440
Free PMC article.